Home/Filings/4/0001209191-23-020293
4//SEC Filing

Hemrajani Rekha 4

Accession 0001209191-23-020293

CIK 0001287098other

Filed

Mar 20, 8:00 PM ET

Accepted

Mar 21, 4:45 PM ET

Size

5.6 KB

Accession

0001209191-23-020293

Insider Transaction Report

Form 4
Period: 2023-03-20
Transactions
  • Award

    Stock Option (right to buy)

    2023-03-20+40,00040,000 total
    Exercise: $4.19Exp: 2033-03-19Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]This grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. 23,333 of the shares underlying this option vested on March 20, 2023 and the remaining 16,667 shares will vest in 15 equal monthly installments thereafter, beginning on April 14, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Issuer

MAXCYTE, INC.

CIK 0001287098

Entity typeother

Related Parties

1
  • filerCIK 0001771213

Filing Metadata

Form type
4
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 4:45 PM ET
Size
5.6 KB